Analyst Ratings for MiniMed Group (MMED)
MMED Rating Summary
MMED Price Target Summary
- Highest: $30.00 (Rothschild Redburn)
- Lowest: $16.00 (Piper Sandler)
- Average: $25.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$25.00 (+42.9%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 84%
Avg. $ Target:
$25.00 (+42.9%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/13/2026 | Rothschild Redburn | Issie Kirby | New Coverage | Buy (N/A) |
30.00 (N/A) |
19.71 (17.49) |
-11.26% | Details |
| 10/12/2026 | Jefferies | Michael Toomey | New Coverage | Hold (N/A) |
22.00 (N/A) |
19.80 (17.49) |
-11.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
